Table 3. Top 25 SNPs resulting from the mixed model analysis for PC2.
SNP | Chr. | Position | Alleles | Minor allele | MAF | Genotypesa | P HWEb | P mixed | Gene regionc | Pos. Rel. gened |
---|---|---|---|---|---|---|---|---|---|---|
rs10499138 | 6 | 128 533 875 | A/T | A | 0.253561 | 30/118/203 | 0.0473 | 1.70E−06 | Receptor-type tyrosine-prot phosphatase kappa precursor (EC 3.1.3.48) | Intron |
rs10491923 | 9 | 76 139 000 | A/G | A | 0.365672 | 49/147/139 | 0.3460 | 2.79E−05 | Nuclear receptor ROR-beta (nuclear receptor RZR-beta) | Upstream |
rs10499136 | 6 | 128 419 828 | A/C | C | 0.296296 | 36/136/179 | 0.2002 | 3.58E−05 | Receptor-type tyrosine-prot phosphatase-kappa precursor (EC 3.1.3.48) | Intron |
rs9308868 | 2 | 103 727 852 | C/T | C | 0.268895 | 25/135/184 | 1.0000 | 6.45E−05 | U3 small nucleolar RNA | Upstream |
rs1555167 | 6 | 62 465 026 | G/T | T | 0.398860 | 57/166/128 | 0.8239 | 9.62E−05 | KH dom-containing, RNA-binding signal transduction-associated prot-2 | Intron |
rs9294311 | 6 | 62 470 112 | C/T | T | 0.398860 | 57/166/128 | 0.8239 | 9.62E−05 | KH dom-containing, RNA-binding, signal transduction-associated prot-2 | Intron |
rs9294314 | 6 | 62 470 480 | A/G | G | 0.398860 | 57/166/128 | 0.8239 | 9.62E−05 | KH dom-containing, RNA-binding, signal transduction-associated prot-2 | Intron |
rs10485162 | 6 | 128 639 684 | C/T | T | 0.145299 | 12/78/261 | 0.0530 | 0.000122 | Receptor-type tyrosine-prot phosphatase-kappa precursor (EC 3.1.3.48) | Intron |
rs514878 | 5 | 73 705 460 | A/G | A | 0.058405 | 2/37/312 | 0.3294 | 0.000132 | Ectoderm-neural cortex 1 protein (ENC-1) | Downstream |
rs10520939 | 5 | 27 970 143 | C/T | T | 0.082813 | 5/43/272 | 0.0516 | 0.000149 | U6 spliceosomal RNA | Downstream |
rs1201494 | 6 | 62 547 842 | A/G | A | 0.398571 | 56/167/127 | 0.9116 | 0.000165 | KH dom-containing, RNA-binding, signal transduction-associated prot-2 | Intron |
rs304408 | 18 | 1 095 249 | A/G | G | 0.245588 | 28/111/201 | 0.0288 | 0.000175 | Putative C18 or f2 variant-3 | Downstream |
rs768166 | 10 | 8 087 556 | A/C | C | 0.228198 | 18/121/205 | 1.0000 | 0.000175 | Transcription initiation factor TFIID subunit-3 | Intron |
rs304409 | 18 | 1 096 342 | A/G | A | 0.246356 | 25/119/199 | 0.2439 | 0.000180 | Pituitary adenylate cyclase-activating polypeptide precursor (PACAP) | Downstream |
rs4936417 | 11 | 117 409 046 | A/G | G | 0.200000 | 20/100/230 | 0.0460 | 0.000202 | Eukaryotic-type signal recognition particle RNA | Upstream |
rs4386936 | 8 | 135 859 109 | A/C | C | 0.219373 | 15/124/212 | 0.6414 | 0.000221 | Zinc finger prot 406 (Protein ZFAT) | Upstream |
rs211004 | 5 | 161 577 376 | C/T | T | 0.370640 | 53/149/142 | 0.2033 | 0.000222 | Gamma-aminobutyric-acid receptor gamma-2 subunit precursor | Downstream |
rs522914 | 6 | 62 592 457 | A/T | A | 0.400285 | 57/167/127 | 0.9115 | 0.000224 | KH dom-containing, RNA-binding, signal transduction-associated prot-2 | Intron |
rs565795 | 6 | 62 597 708 | A/G | G | 0.400285 | 57/167/127 | 0.9115 | 0.000224 | KH dom-containing, RNA-binding, signal transduction-associated prot-2 | Intron |
rs265360 | 6 | 129 579 569 | A/G | A | 0.272727 | 33/120/188 | 0.0404 | 0.000247 | Laminin-alpha-2 chain precursor (laminin M-chain) | Intron |
rs9312176 | 4 | 67 882 411 | A/G | A | 0.456522 | 74/167/104 | 0.6647 | 0.000254 | Similar to interferon-induced transmembrane prot-3 | Downstream |
rs1544044 | 20 | 14 459 168 | C/T | T | 0.465318 | 72/178/96 | 0.5892 | 0.000257 | OTTHUMP00000030317 | Intron |
rs10493937 | 1 | 101 115 238 | A/T | A | 0.472934 | 85/162/104 | 0.1650 | 0.000267 | Exostosin-like-2 (EC 2.4.1.223) | Intron |
rs1358815 | 6 | 57 471 407 | G/T | G | 0.464183 | 73/178/98 | 0.6680 | 0.000274 | DNA primase large subunit (EC 2.7.7.-) | Intron |
rs6489314 | 12 | 1 627 431 | A/C | A | 0.341642 | 47/139/155 | 0.0916 | 0.000300 | Adiponectin receptor prot-2 | Upstream |
Abbreviations: Chr., chromosome; dom, domain; MAF, minor allele frequency; P HWE, P-value resulting after Hardy–Weinberg equilibrium testing; P Mixed, P-value resulting mixed-model analysis (indicated in bold); Pos. Rel. Gene, position of the SNP relative to the gene listed in the previous column; prot, protein.
The number of homozygotes for the minor allele/the number of heterozygotes/the number of homozygotes for the major allele.
The Hardy–Weinberg equilibrium P-value should be larger than 0.001 for the SNP genotyping to be valid.
‘/' indicates that this SNP was not located within a gene region.
‘Upstream' or ‘Downstream' was based on the Affymetrix annotation.